TOKYO -- Japan's push to triple its stockpile of anti-flu medicine Avigan for coronavirus treatment has proven a challenge as the lack of a raw ingredient from China forces Fujifilm Holdings to switch to a domestic supplier.
Coronavirus
Avigan ingredient shortage hits Japan stockpile plan
Lack of element from China spurs to push to find domestic suppliers
Avigan developer Fujifilm is turning to domestic sources of raw materials to make the drug after Japanese Prime Minister Shinzo Abe announced the goverment plans to increase its stockpile.
Read Next
Latest on Coronavirus
